抗結核薬による肝損傷の遺伝的および臨床的危険因子:エチオピア中部における前向きなコホート研究からの洞察
Caroline Klindt1,2, Andre Fuchs3,4,5, Kristina Behnke1
1Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Infection
|September 4, 2025
まとめ
エチオピアでは,結核治療中に薬剤による肝損傷 (DILI) が一般的であり,しばしば早期に発生する. 都市生活と肝硬直は重度のDILIを予測しますが 遺伝的要因は関連していません
科学分野:
- ヘパトロジー
- 薬用警戒について
- 結核の研究
背景:
- 薬物による肝損傷 (DILI) は,特にサハラ以南のアフリカで結核治療 (TBT) の重要な懸念事項である.
- エチオピアのTBT患者におけるDILIの頻度,タイミング,リスク要因に関するデータは限られている.
- 肝臓の輸送タンパク質 (HTPP) の遺伝的多形性は,DILIに潜在的に寄与する.
研究 の 目的:
- エチオピアのTBT患者におけるDILIの発生率とタイミングを決定する.
- DILIに関連するリスク要因を特定する.
- HTPPとDILIリスクとの関連を調査する.
主な方法:
- TBT開始前の424人の結核患者の前向きな研究.
- 治療の最初の8週間の肝機能検査
- 社会人口統計,ライフスタイル,ウイルス併感染,HTPP,過渡性エラストグラフィ (TE) による肝硬度を含むベースラインデータ収集.
- 多変数ロジスティック回帰,コックスモデル,ファインとグレイの競合リスク分析を用いた統計分析.
主要な成果:
- 累積的なDILI発生率は16. 0%で,重度のDILIは4. 2%で,主に最初の2週間でした.
- 都市部での居住は,DILIリスクの増加と関連していた (OR 2. 00,HR 1.80)
- 都市居住 (sHR 6. 26) と病理性TE (sHR 5.23) は,競合するリスクの分析において重度のDILIを予測した.
- 調査されたHTPPとDILIとの間に有意な関連性は見つかりませんでした.
結論:
- DILIはエチオピア人の患者で発生する 早期合併症です
- 社会人口学的要因と肝硬直の治療前の評価は,高リスクの個人を特定することができます.
- このアプローチは,資源が限られた環境でのDILI管理のための実用的な戦略を提供します.
さらに関連する動画
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.9K
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.9K
関連する概念動画
01:29Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
01:28Pulmonary Tuberculosis V
236
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
236
01:26Pulmonary Tuberculosis IV
196
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
196
01:31Pulmonary Tuberculosis III
438
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
438
01:28Pulmonary Tuberculosis II
339
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
339
01:16Hepatic Drug Excretion: Influencing Factors
214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214